tm
Seeing Is Believing
tm
Seeing Is Believing
Prevail Therapeutics's activity chart (see below) currently has 20 price targets and 17 ratings on display.
Analysts average stock forecasts to be materialized ratio is 70.91% with an average time for these price targets to be met of 191.45 days.
Most recent stock forecast was given by from WEDBUSH on 23-Dec-2020. First documented stock forecast 15-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Jul-2019
$22
$-1 (-4.35%)
$22
5 years 10 months ago
(23-Dec-2020)
2/5 (40%)
$-1.18 (-5.09%)
234
Buy Since 16-Jul-2020
$23
5 years 10 months 6 days ago
(17-Dec-2020)
2/2 (100%)
$-0.17 (-0.73%)
84
Buy Since 06-Mar-2020
$24
$1 (4.35%)
5 years 10 months 8 days ago
(15-Dec-2020)
0/2 (0%)
$1.25 (5.49%)
Buy Since 09-Apr-2020
$24.5
$1.5 (6.52%)
$20
5 years 10 months 9 days ago
(15-Dec-2020)
4/5 (80%)
$1.75 (7.69%)
206
Buy Since 15-Jul-2019
$20
$-3 (-13.04%)
$20
6 years 9 months 26 days ago
(27-Dec-2019)
2/2 (100%)
$4.19 (26.50%)
437
What is PRVL (Prevail Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PRVL (Prevail Therapeutics)?
Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?
Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?
Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?
